Clinical significance of serum T helper 1/T helper 2 cytokine shift in patients with non-small cell lung cancer

Oncology Letters

Volumn 8, Issue 4, 2014, Pages 1682-1686

  Li, Jun ^a   Wang, Zhenhua ^a   Mao, Kai ^a   Guo, Xixi ^a  

^a XINXIANG CENTRAL HOSPITAL   (China)

Author keywords

Non small cell lung cancer; Postoperative survival time; Relapse; T helper 1 T helper 2 cytokine shift

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; RECURRENCE RISK; SURVIVAL RATE; SURVIVAL TIME; TH1 CELL; TH2 CELL;

EID: 84923068147     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2391     Document Type: Article

References (22)

1. Boukovinas I, Tsakiridis K, Zarogoulidis P, Machairiotis N, Katsikogiannis N, Kougioumtzi I and Zarogoulidis K: Neo-adjuvant chemotherapy in early stage non-small cell lung cancer. J Thorac Dis 5 (Suppl 4): S446-S448, 2013.
2. Zarogoulidis K, Zarogoulidis P, Darwiche K, et al: Treatment of non-small cell lung cancer (NSCLC). J Thorac Dis 5 (Suppl 4): S389-S396, 2013.
3. Baltayiannis N, Chandrinos M, Anagnostopoulos D, et al: Lung cancer surgery: an up to date. J Thorac Dis 5 (Suppl 4): S425-S439, 2013.
4. Yuanying Y, Lizhi N, Feng M, et al: Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer. Cryobiology 67: 235-240, 2013.
5. Becker Y: Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy-a review. Virus Genes 33: 235-252, 2006.
6. Pinto RA, Arredondo SM, Bono MR, Gaggero AA and Díaz PV: T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol. Pediatrics 117: e878-e886, 2006.
7. Krohn M, Listing M, Tjahjono G, Reisshauer A, Peters E, Klapp BF and Rauchfuss M: Depression, mood, stress, and Th1/Th2 immune balance in primary breast cancer patients undergoing classical massage therapy. Support Care Cancer 19: 1303-1311, 2011.
8. Green VL, Alexandropoulou A, Walker MB, Walker AA, Sharp DM, Walker LG and Greenman J: Alterations in the Th1/Th2 balance in breast cancer patients using reflexology and scalp massage. Exp Ther Med 1: 97-108, 2010.
9. Hong CC, Yao S, McCann SE, et al: Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers. Breast Cancer Res Treat 139: 477-488, 2013.
10. Wei H, Sun R, Xiao W, Feng J, Zhen C, Xu X and Tian Z: Traditional Chinese medicine Astragalusreverses predominance of Th2 cytokines and their up-stream transcript factors in lung cancer patients. Oncol Rep 10: 1507-1512, 2003.
11. Liang J, Li Y, Liu X, Xu X and Zhao Y: Relationship between cytokine levels and clinical classification of gastric cancer. Asian Pac J Cancer Prev 12: 1803-1806, 2011.
12. Chen G, Wang QR and Hu SM: Relationship between Th1/Th2 drift and T-bet/GATA3 gene expression in elderly patients with non-small cell lung cancer. Hua Zhong Ke Ji Da Xue Xue Bao 5: 509-512, 2011 (In Chinese).
13. Ito N, Suzuki Y, Taniguchi Y, Ishiguro K, Nakamura H and Ohgi S: Prognostic significance of T helper 1 and 2 and T cytotoxic 1 and 2 cells in patients with non-small cell lung cancer. Anticancer Res 25: 2027-2031, 2005.
14. Sculier JP: Non small cell lung cancer. Eur Respir Rev 22: 33-36, 2013.
15. Zheng YW, Li RM, Zhang XW and Ren XB: Current adoptive immunotherapy in non-small cell lung cancer and potential influence of therapy outcome. Cancer Invest 31: 197-205, 2013.
16. Ito N, Nakamura H, Metsugi H and Ohgi S: Dissociation between T helper type 1 and type 2 differentiation and cytokine production in tumor-infiltrating lymphocytes in patients with lung cancer. Surg Today 31: 390-394, 2001.
17. Filipits M and Pirker R: Predictive markers in the adjuvant therapy of non-small cell lung cancer. Lung Cancer 74: 355-363, 2011.
18. Jemal A, Murray T, Ward E, et al: Cancer statistics, 2005. CA Cancer J Clin 55: 10-30, 2005.
19. Weng Q, Yu LL, Cai YQ and Tang J: Relationship between peripheral blood cytokine expression and recurrence in 58 cases with ovarian cancer. Zhong Liu Xue Za Zhi 11: 861-863, 2010 (In Chinese).
20. Francipane MG, Alea MP, Lombardo Y, Todaro M, Medema JP and Stassi G: Crucial role of interleukin-4 in the survival of colon cancer stem cells. Cancer Res 68: 4022-4025, 2008.
21. Conticello C, Pedini F, Zeuner A, et al: IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins. J Immunol 172: 5467-5477, 2004.
22. Cui X, Yang SC, Sharma S, Heuze-Vourc'h N and Dubinett SM: IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer. Biochem Biophys Res Commun 343: 995-1001, 2006.